01/25/2026
The "Aspirin Conundrum" Solved: Is a Daily Pill Right for You?
For years, the medical community has debated whether daily low-dose aspirin is a "life-saver" or a "risk factor" for primary prevention of heart disease. While it can prevent heart attacks, it also carries a significant risk of serious internal bleeding.
At DeSimone Functional Medicine, we don’t believe in "one-size-fits-all" medicine. A new study published in the American Journal of Preventive Cardiology suggests that the answer to the aspirin question may be found in your DNA—specifically the LP(a) gene.
The Precision Medicine Advantage:
• The Genetic Marker: A specific variant (rs3798220) in the LP(a) gene can increase your baseline risk of heart disease by more than two-fold.
• The Discovery: For those who carry this variant, daily low-dose aspirin is highly effective, reducing their elevated risk back to the level of a person without the variant.
• The "NNT" Difference: In patients with this gene, the "Number Needed to Treat" (NNT) to prevent one major event is as low as 34—making it as effective as many high-powered cholesterol-lowering medications.
• The Decision: For those without the gene, the benefits are much smaller, and the risk of bleeding may outweigh the potential reward.
One Test, One Lifetime. This simple genetic test costs roughly $25–$50 and needs to be performed only once in your life to provide lifelong clarity. It is an essential tool for identifying root-cause risks and moving beyond reactive care.
Are you taking aspirin? Let’s make sure it’s actually working for you.
(a)